Gus Adapon, Els

Evolution Services is an Information Technology Consulting Firm that delivers the nation’s best temporary professional IT specialists to your company. We are an IT Staff Augmentation consulting firm providing consulting, option to hire and full time hire resources. With vast experience in providing IT resources across the country we pride ourselves in adhering to a high standard of business ethics. Our deep understanding of your industry including new software, platforms, tools, concepts and methodologies enables us to provide this high level of service. We are large enough to satisfy even the largest clients while also small enough to provide TLC, not just for the client but for all our consultants. Whether you’re a Fortune 500 firm or a rapidly growing business, our temporary staffing solutions quickly and easily connect you to top talent. Take your business to the next level. Join the Evolution.

US/Asia-based venture capital portfolio focused on emerging technologies in the biotech & healthcare sectors.

OBI Pharma Inc. (OBI) is a global clinical stage oncology company that is headquartered in Taiwan. The company also has subsidiaries in the United States and Australia. It was founded in 2002 by Dr. Michael Chang, an accomplished biotech entrepreneur in the United States. Its stocks were issued publicly in 2012. Subsequently, the company was successfully listed on the Taipei Exchange (TWO. 4174) in 2015. OBI focuses on innovative research and development for cancer therapies and aims to develop “first-in-class” and “best-in-class” ground-breaking drugs. It aspires to market these drugs worldwide with a “Made in Taiwan” branding and to provide new treatment options for patients with unmet medical needs. The core value of OBI lies in its passion to develop and deliver a portfolio of unique antibody-drug conjugates (ADC) drugs for patients, in addition to its promising Globo series (e.g., Globo H) of cancer therapeutic vaccines. This evolving portfolio includes a spectrum of cancer targets, such as TROP2, Nectin4, HER2, etc. These ADCs are built based on two distinct ADC technology platforms, each with different characteristics. Both platforms are customizable and offer a “plug-and-play” advantage through a specialized site-specific conjugation using a proprietary enzyme. With the added value of scalability, these “plug-and-play” technology platforms enable ADC development to be relatively simple and efficient. OBI is interested in commercializing its ADC technology platforms and looks forward to collaborating with biotech and pharmaceutical companies by enabling “first-in-class” and “best-in-class” therapeutic candidates for further development.

Forumosa.com is Taiwan's largest online community in English. It is a volunteer community with almost 30 moderators (The Mod Squad). Forumosa began in 1998 under a different name: ORIENTED.org - today, Forumosa is the core website in a group that includes Taiwanted.com and Taiwanease.com